GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the fourth quarter and full year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results